Testing the Short-Term Efficacy of a Lipid-Lowering Nutraceutical in the Setting of Clinical Practice: A Multicenter Study

Journal of Medicinal Food

Volumn 18, Issue 11, 2015, Pages 1270-1273

  Cicero, Arrigo F G ^a   Derosa, Giuseppe ^b   Pisciotta, Livia ^c   Barbagallo, Carlo ^d  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d UNIVERSITY OF PALERMO   (Italy)

Author keywords

Dietary supplements; Hypercholesterolemia; Monacolins; Nutraceuticals; Phytosterols; PUFA; Red yeast rice

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTILIPEMIC AGENT; ASPARTATE AMINOTRANSFERASE; CHOLESTIN; CREATINE KINASE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHYTOSTEROL; PLACEBO; POLYUNSATURATED FATTY ACID; TRIACYLGLYCEROL; BIOLOGICAL PRODUCT; CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT; LIPID; MEVINOLIN; UNSATURATED FATTY ACID;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CLINICAL PRACTICE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MULTICENTER STUDY; OPEN STUDY; PRIMARY POLYGENIC HYPERCHOLESTEROLEMIA; PRIORITY JOURNAL; SHORT COURSE THERAPY; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; CHEMISTRY; COMPLICATION; CONTROLLED CLINICAL TRIAL; DIETARY SUPPLEMENT;

ADULT; ANTICHOLESTEREMIC AGENTS; BIOLOGICAL PRODUCTS; CHOLESTEROL; CHOLESTEROL, LDL; DIETARY SUPPLEMENTS; FATTY ACIDS, UNSATURATED; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; LIPIDS; LOVASTATIN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PHYTOSTEROLS; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 84946014500     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2015.0024     Document Type: Article

References (21)

1. Baigent C, Keech A, Kearney PM et al.: Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90, 056 participants in 14 randomised trials of statins. Lancet 2005;366:1267-1278.
2. Ray KK, Seshasai SR, Erqou S, Sever P, Jukema JW, Ford I, Sattar N: Statins and all-cause mortality in high-risk primary prevention: A meta-analysis of 11 randomized controlled trials involving 65, 229 participants. Arch Intern Med 2010;170:1024-1031.
3. Jacobson TA: Toward ''pain-free'' statin prescribing: Clinical algorithm for diagnosis and management of myalgia. Mayo Clin Proc 2008;83:687-700.
4. Cicero AF, Ferroni A, Ertek S: Tolerability and safety of commonly used dietary supplements and nutraceuticals with lipidlowering effects. Expert Opin Drug Saf 2012;11:753-766.
5. Cicero AF, Borghi C: Evidence of clinically relevant efficacy for dietary supplements and nutraceuticals. Curr Hypertens Rep 2013;15:260-267.
6. European Food Safety Authority: Scientific opinion on the substantiation of health claims related to monacolin K from red yeast rice and maintenance of normal blood LDL cholesterol concentrations (ID 1648, 1700) pursuant to Article 13(1) of Regulation (EC) No 1924/2006. EFSA J 2011;9:2304-2319.
7. EFSA Committee: Scientific opinion on the substantiation of health claims related to eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), docosapentaenoic acid (DPA) and maintenance of normal cardiac function (ID 504, 506, 516, 527, 538, 703, 1128, 1317, 1324, 1325) [.] pursuant toArticle 13(1) of Regulation (EC) No 1924/2006. EFSA J 2010;8:1796.
8. NCEP ATP III Expert Panel: Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA 2001;285:2486-2497.
9. Cicero AFG, Brancaleoni M, Laghi L, Donati F, Mino M: Antihyperlipidaemic effect of a Monascus purpureus brand dietary supplement on a large sample of subjects at low risk for cardiovascular disease: A pilot study. Complement Ther Med 2005;13:273-278.
10. Poli A, Marangoni F, Paoletti R, et al.: Nutrition foundation of Italy. Non-pharmacological control of plasma cholesterol levels. Nutr Metab Cardiovasc Dis 2008;18:S1-S16.
11. Catapano AL, Reiner Z, De Backer G, et al.: ESC/EAS Guidelines for the management of dyslipidaemias: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis 2011;217:3-46.
12. Ras RT, Geleijnse JM, Trautwein EA: LDL-cholesterol-lowering effect of plant sterols and stanols across different dose ranges: A meta-analysis of randomised controlled studies. Br J Nutr 2014;112:214-219.
13. Banegas JR, López-García E, Dallongeville J, et al.: Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: The EURIKA study. Eur Heart J 2011;32:2143-2152.
14. Saha S, Gerdtham UG, Johansson P: Economic evaluation of lifestyle interventions for preventing diabetes and cardiovascular diseases. Int J Environ Res Public Health 2010;7:3150-3195.
15. King DE, Mainous AG 3rd, Matheson EM, Everett CJ: Impact of healthy lifestyle on mortality in people with normal blood pressure, LDL cholesterol, and C-reactive protein. Eur J Cardiovasc Prev Rehabil 2013;20:73-79.
16. Cicero AFG, Derosa G, D'angelo A, et al.: Gender-specific haemodynamic and metabolic effects of a sequential training programme on overweight-obese hypertensives. Blood Press 2009;18:111-116.
17. Cicero AF, Tartagni E, Ertek S: Nutraceuticals for metabolic syndrome management: From laboratory to benchside. Curr Vasc Pharmacol 2014;12:565-571.
18. Cicero AF, Derosa G, Parini A, et al.: Red yeast rice improves lipid pattern, high-sensitivity C-reactive protein, and vascular remodeling parameters in moderately hypercholesterolemic Italian subjects. Nutr Res 2013;33:622-628.
19. Roza JM, Xian-Liu Z, Guthrie N: Effect of citrus flavonoids and tocotrienols on serum cholesterol levels in hypercholesterolemic subjects. Altern Ther Health Med 2007;13:44-48.
20. Bard JM, Paillard F, Lecerf JM: Effect of phytosterols/stanols on LDL concentration and other surrogate markers of cardiovascular risk. Diabetes Metab 2015;41:69-75.
21. Abu Mweis SS, Marinangeli CP, Frohlich J, Jones PJ: Implementing phytosterols into medical practice as a cholesterollowering strategy: Overview of efficacy, effectiveness, and safety. Can J Cardiol 2014;30:1225-1232.